Pfizer and GSK Spin off Consumer Health Divisions Into a New Joint Venture

New York-based Pfizer and London-based GlaxoSmithKline (GSK) have decided to work together to create a global consumer healthcare company.

Under the terms of the agreement, Pfizer will combine its consumer healthcare business with GSK’s existing consumer healthcare business. The combined global sales were about $12.7 billion last year.